A BMT CTN phase II trial of unrelated donor marrow transplantation for children with severe sickle cell disease.

Document Type

Journal Article

Publication Date

9-13-2016

Journal

Blood

DOI

10.1182/blood-2016-05-715870

Peer Reviewed

1

Share

COinS